TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -2 | 1 | 11 | -11 | -20 | 33 | 2 |
| P | %wins | 0 | 50 | 100 | 0 | 0 | 50 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/4/08 13:58 | 7/31/08 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stigliano Len F | MD | O | VP,CFO,T | P.d | 0 | 0.00 | 1 | 11 | 106 | 21 | D | -26 | -6 | -18 | 0 | 0 | 5 | -7 | 6 | -3 | -2 | 10 | -20 | -37 | 72 |
8/27/07 14:37 | 8/24/07 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stigliano Len F | MD | O | VP,CFO,T | P | 31 | 3.14 | 2 | 10 | New | 10 | D | 222 | -19 | -16 | 6 | 2 | 14 | 7 | 2 | -1 | 4 | 12 | -1 | -2 | -6 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |